Treatment of Opioid Use Disorder Course
(Includes waiver qualifying requirements)
When: Friday, October 18, 2019, 8 am-5 pm
Where: Sioux Falls - University of South Dakota Sanford School of Medicine, 1400 W 22nd St
Registration: Contact Carletta Hauck at email@example.com or 605-882-3583 or contact Mark East at firstname.lastname@example.org or 605-336-1965
Cost: $199. The South Dakota Department of Social Services will pay the registration fee for the first 30 qualified South Dakota providers. Out of state providers are welcome to attend for the $199 registration fee.
The ASAM Treatment of Opioid Use Disorder Course covers all evidence-based practices and medications for treating patients with opioid use disorder.
The ASAM Treatment of Opioid Use Disorder Course is designed for:
• Physicians, nurse practitioners, physician assistants, and health care team members working with patients with opioid use disorder.
• Physicians, nurse practitioners, and physician assistants who wish to obtain a waiver to prescribe buprenorphine for oﬃce-based treatment of opioid use disorders.
Our case-based learning format will show you how to apply this new knowledge.
You will learn how to:
• Offer treatments for patients with opioid use disorder.
• Identify and assess patients who are appropriate for treatment with medications.
• Discuss the psychiatric and medical comorbidities associated with opioid addiction.
• Apply for a waiver to prescribe buprenorphine to patients with opioid use disorders.
This training satisfies eight hours of education requirements for providers to qualify for a DEA DATA2000 waiver. Upon completion of this course, physicians qualify for the waiver to prescribe buprenorphine in an office-based setting. NPs and PAs can qualify after completing an additional 16 hours provided by ASAM, the American Association of Nurse Practitioners, and the American Academy of PAs.
Sponsored by the South Dakota State Medical Association, South Dakota Academy of Family Physicians and American Society of Addiction Medicine.
ACCME ACCREDITATION STATEMENT: The American Society of Addiction Medicine (ASAM) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to sponsor continuing medical education for physicians.
AMA CREDIT DESIGNATION STATEMENT: The American Society of Addiction Medicine designates this live activity for a maximum of 8 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AAFP ACCREDITATION STATEMENT: Application for CME Credit has been filed with the American Academy of Family Physicians. Determination of Credit is pending.
Funding for this conference was made possible by the South Dakota Department of Social Services.
Other Educational Opportunities
Prescription drug and opioid abuse and their related consequences pose significant risk and problems to the health of the public. Consequently, opioid and prescription drug often lead to poor overall well-being and welfare, poor health issues and other risky behaviors, and impose significant costs on our society.
The following educational programs, which are endorsed by the SDSMA Ad Hoc Committee on Pain Management and Prescription Drug Abuse, provide evidence-based guidelines for prescribing opioids to both effectively treat pain and minimize patient risk.
Controlled Substances Stewardship Provider Education Module 1
Controlled Substances Stewardship Provider Education Module 2
Controlled Substances Stewardship Provider Education Module 3
Controlled Substances Stewardship Provider Education Module 4
Videos and presentations from the SDSMA Center for Physician Resources opioid webinar series are below:
Opioids: Diversion, Addiction and Treatment - Webinar and PowerPoint
Understanding Diversion and How to Combat It - Webinar and PowerPoint
Addiction and its Impact on the Brain - Webinar and PowerPoint
Drug Addiction in Pregnancy - Webinar and PowerPoint
Safe and Effective Tapering of Opioids - Webinar and PowerPoint
Beyond MAT - Webinar and PowerPoint